Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
460.10    0.50 (0.11%)
Bid:
459.90
Ask:
460.30
Spread: 0.40 (0.087%)
Market Cap: £5.73b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Financing Update

4 Aug 2020 07:00

RNS Number : 0505V
Melrose Industries PLC
04 August 2020
 

MELROSE INDUSTRIES PLC

 

4 August 2020

 

 

FINANCING UPDATE

 

Melrose Industries PLC ("Melrose" or the "Group") today issues an update on financing.

 

Following the trading updates on 30 March 2020 and 22 July 2020, Melrose has now agreed amended arrangements with its banking syndicate including improved financial covenants to 31 December 2022. Beyond that date the Group reverts to the original covenants for the balance of the facilities' term. These amendments cover all the Group's primary borrowing arrangements that contain financial covenants.

 

The Group's committed c.£3.2 billion revolving credit facility is repayable in January 2023 and the Group's committed term loan of c.£0.9 billion can be extended to April 2024 at Melrose's option. In addition to these committed banking lines the Group has two bonds: a £450 million bond maturing in September 2022 and a £300 million bond maturing in May 2032, neither of which contain financial covenants.

 

Melrose is grateful for the continued support of its lending banks which means that it has the flexibility it needs to continue to focus on cash generation and adapting the Group to current market conditions. The new financial covenants have been designed to give Melrose considerable headroom and flexibility.

 

There is a modest cash cost to secure this amendment but there is no change to previously agreed interest rate calculations. Melrose has passed its covenant tests for 30 June 2020 and would not in fact have needed the net debt: EBITDA waiver granted previously.

 

The improved financial covenants are shown in the table below:

 

Financial

Covenant

31 December 2020

30 June 2021

31 December 2021

30 June 2022

31 December 2022

Net debt :EBITDA

Waiver*

Waiver

5.25x**

4.75x**

4.0x**

EBITDA :Net finance charges

2.5x

3.0x

3.0x

3.25x

4.0x

*Announced on 30 March 2020

**Subject to downward adjustments upon certain material disposals

 

Following 31 December 2022, the financial covenants revert to 3.5x (for net debt: EDITDA) and remain at 4x (for EBITDA: net finance charges).

 

 

 

Simon Peckham, CEO of Melrose Industries PLC, said:

"We have now put in place new amended arrangements with our banks that last until the end of 2022. We thank our banks again for their continued support which gives us the headroom and flexibility to continue to focus on cash generation and adapt the Group as needed. Melrose also retains over £1 billion of cash liquidity. We are confident that we can position the Group to produce good returns for Shareholders."

- ends

 

Enquiries:

 

 

Montfort Communications:

Nick Miles

+44 (0) 20 3514 0897

+44 (0) 7973 130 669

miles@montfort.london

Charlotte McMullen

+44 (0) 20 3514 0897

+44 (0) 7921 881 800

mcmullen@montfort.london

Melrose Investor Relations:

+44 (0) 7974 974690

ir@melroseplc.net

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEZLBBBVLXBBV
Date   Source Headline
8th Jun 202612:25 pmRNSTR1 - Notification of Major Holdings
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20269:07 amRNSTR-1: Standard Form-Notification of Major Holdings
1st Jun 20269:02 amRNSTR1 - Notification of major holdings
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 202610:34 amRNSTR-1: Notification of major holdings
27th May 20264:26 pmRNSPDMR Announcement
27th May 20268:32 amRNSUpdate on Garden Grove facility in California
26th May 20267:09 amRNSOngoing incident at Garden Grove facility
26th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTR-1: Standard Form-Notification of Major Holdings
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTR-1: Standard form for notification
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20269:36 amRNSNotifications of Transactions of PDMR
5th May 20264:43 pmRNSNotifications of Transactions of PDMR
5th May 20264:23 pmRNSTransaction in Own Shares
5th May 20267:00 amRNSDirector Change / CFO Appointment
1st May 20268:26 amRNSDirector/PDMR Shareholding
29th Apr 20262:15 pmRNSResults of AGM
29th Apr 20267:00 amRNSAGM TRADING UPDATE
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20269:18 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:09 amRNSNotifications of Transactions of PDMR
23rd Mar 20264:05 pmRNSAnnual Report and Notice of Annual General Meeting
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20269:52 amRNSNotification of Transactions of PDMR
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20263:19 pmRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSNotification of Transactions of PDMR
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202610:39 amRNSTR-1: Standard Form-Notification of Major Holdings
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:12 amRNSDirector Declaration - 2nd March 2026
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSFINAL RESULTS
27th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.